Back

Plasma eicosanoid profiling in the course of proprotein convertase subtilisin-kexin type 9 inhibition: insights from a metabolomic analysis

28 August 2022 (08:15 - 09:00)
Organised by:
Congress Presentation Part of: Targeting lipids and lipid-related pathways in cardiovascular disease Lipids, Metabolism ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Lore Schrutka

Medical University of Vienna, Vienna (Austria)

6 More presentations in this session

Presentation thumbnail
A novel direct inducible nongenetic murine model of diabetes-aggravated atherosclerosis
Doctor S. Gaul (Leipzig, DE)
Abstract Slides
Presentation thumbnail
Molecular imaging of experimental atherosclerosis using anti-malondialdehyde-modified low-density lipoprotein humanised antibody fragment targeted nanoparticles
Doctor A. Hartley (London, GB)
Abstract Slides
Presentation thumbnail
LXR-beta signalling is a key mediator in the pathogenesis of aortic valve stenosis and its prevention by saringosterol
Doctor M. Noethel (Bonn, DE)
Abstract Slides
Presentation thumbnail
Comparison of various low density lipoprotein cholesterol calculators. Is it time for the Friedewald equation to go?
Doctor H. Chandran (Chennai, IN)
Abstract Slides
Presentation thumbnail
Human macrophages are immunoprofiled by pericardial fluid small extracellular vesicles modulating lipid metabolism mechanisms.
Doctor S. Ben-Aicha (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Targeting lipids and lipid-related pathways in cardiovascular disease

The Event

Event poster

ESC Congress 2022

28 August 2022 08:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources